Literature DB >> 12589702

Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.

Paula Berstad1, Ingebjørg Seljeflot, Marit B Veierød, Elsa M Hjerkinn, Harald Arnesen, Jan I Pedersen.   

Abstract

We have investigated the effect of fish oil supplementation on the association between serum non-esterified fatty acid (NEFA) pattern and atherosclerotic activity. We studied correlations between serum non-esterified very long-chain eicosapentaenoic (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA) and biochemical markers of endothelial activation before and after 18-months intervention with fish oil supplementation. The fish oil supplementation consisted of 2.4 g of EPA and DHA per day, with corn oil as placebo. Elderly men ( n =171) with high risk for coronary heart disease were divided into four intervention groups in a factorial design: fish oil supplementation ( n =44), dietary intervention ( n =42), fish oil supplementation+dietary intervention ( n =47) or placebo ( n =38). The composition of fasting NEFA was analysed before and after intervention by GLC. Circulating endothelial markers were analysed by ELISA. A statistically significant positive correlation between the change in serum non-esterified DHA and soluble vascular cell adhesion molecule-1 (sVCAM-1) was found in the pooled group that received fish oil supplementation ( n =91; Spearman's correlation coefficient r =0.24, P =0.02). No such correlation was found in the pooled group without fish oil supplementation ( n =80). Furthermore, there was a significant negative correlation between the change in serum non-esterified EPA and the relative change in sVCAM-1 in the group that did not receive fish oil supplementation ( r =-0.34, P =0.002). No such correlation was found in the group with fish oil supplementation. We conclude that large increase in serum non-esterified EPA and DHA, which can only be attained by supplementation, might increase inflammation in vascular endothelium. A moderate dietary increase in fish oil intake may, however, have an effect on decreasing inflammatory markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589702     DOI: 10.1042/CS20020349

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  21 in total

Review 1.  The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid.

Authors:  Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

Review 2.  Nutrition and the endothelium.

Authors:  Esther Lopez-Garcia; Frank B Hu
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

Review 3.  From alga to omega; have we reached peak (fish) oil?

Authors:  Paul R Clayton; Szabolcs Ladi
Journal:  J R Soc Med       Date:  2015-09       Impact factor: 5.344

Review 4.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 5.  Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.

Authors:  Baukje de Roos; Yiannis Mavrommatis; Ingeborg A Brouwer
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

6.  Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Ka He; Kiang Liu; Martha L Daviglus; Nancy Swords Jenny; Elizabeth Mayer-Davis; Rui Jiang; Lyn Steffen; David Siscovick; Michael Tsai; David Herrington
Journal:  Am J Cardiol       Date:  2009-03-04       Impact factor: 2.778

Review 7.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 8.  Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors.

Authors:  Mari C W Myhrstad; Kjetil Retterstøl; Vibeke H Telle-Hansen; Inger Ottestad; Bente Halvorsen; Kirsten B Holven; Stine M Ulven
Journal:  Inflamm Res       Date:  2011-01-13       Impact factor: 4.575

9.  Plasma ω-3 and ω-6 PUFA Concentrations and Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Parveen K Garg; Weihua Guan; Sarah Nomura; Natalie Weir; Amy B Karger; Daniel Duprez; Susan R Heckbert; Michael Y Tsai
Journal:  J Nutr       Date:  2021-06-01       Impact factor: 4.798

10.  Effects of EPA supplementation on plasma fatty acids composition in hypertriglyceridemic subjects with FABP2 and PPARα genotypes.

Authors:  Hamideh Pishva; Mohsen Amini; Mohammad Reza Eshraghian; Saeed Hosseini; Soltan Ali Mahboob
Journal:  J Diabetes Metab Disord       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.